[Combination of low doses of 131-iodine and synthetic antithyroid agents for prolonged treatment in Basedow's disease. Apropos of 165 cases].
D000328:Adult; D000368:Aged; D013956:Antithyroid Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006111:Graves Disease / Q000188:drug therapy* / Q000532:radiotherapy; D006801:Humans; D006980:Hyperthyroidism / Q000209:etiology; D007037:Hypothyroidism / Q000209:etiology; D007455:Iodine / Q000627:therapeutic use; D007456:Iodine Isotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011878:Radiotherapy / Q000009:adverse effects; D011879:Radiotherapy Dosage; D013970:Thyronines / Q000627:therapeutic use
D013956:Antithyroid Agents; D007456:Iodine Isotopes; D013970:Thyronines; D007455:Iodine
Association de faibles doses d'iode 131 et d'antithyroidiens de synthése en cure trés prolongée pour le traitement de la maladie de Basedow. A propos de 165 observations.